Neurology
Ecopipam Shows Promise for Tourette Syndrome in Young People
In a randomized trial, ecopipam reduced tic severity versus placebo in young people with Tourette syndrome, with tolerability that supports further evaluation of dopamine D1 blockade.
Dr. Abu Bakar · October 4, 2026 · 7 min